|
May 7
|
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
|
|
May 6
|
Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ...
|
|
May 6
|
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
|
|
May 4
|
New Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting
|
|
May 3
|
Citi Just Cut Its Price Target on These 3 Stocks
|
|
Apr 30
|
BioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
|
|
Apr 29
|
BioMarin Pharmaceutical Investors Overfocused on Roctavian, Distracted From Enzyme Replacement Therapies, UBS Says
|
|
Apr 27
|
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
|
Apr 27
|
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
|
|
Apr 26
|
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
|
|
Apr 26
|
BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
|
|
Apr 26
|
Pfizer hemophilia gene therapy arrives in US to uncertain future
|
|
Apr 25
|
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
|
|
Apr 25
|
BioMarin drops drug programs in pipeline cull
|
|
Apr 25
|
Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
|
|
Apr 25
|
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
|
|
Apr 25
|
Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...
|
|
Apr 24
|
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Apr 24
|
BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates
|
|
Apr 24
|
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
|